中国医药：2025年第五次临时股东大会决议公告

Group 1 - The core point of the article is that China Pharmaceutical announced the convening of its fifth extraordinary general meeting of shareholders for 2025 on August 8, 2025, to review and approve the proposal to increase the estimated guarantee limit for the year 2025 [2] Group 2 - The meeting is scheduled to take place on August 8, 2025, indicating the company's proactive approach to governance and financial management [2] - The proposal under review pertains to the estimated guarantee limit for the year 2025, which suggests potential strategic financial maneuvers by the company [2]